Oramed Pharmaceuticals Inc (ORMP)
2.195
-0.14
(-5.79%)
USD |
NASDAQ |
Apr 18, 16:00
2.195
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 0.674M |
March 31, 2023 | 0.666M |
December 31, 2022 | 0.681M |
September 30, 2022 | 0.682M |
June 30, 2022 | 0.674M |
March 31, 2022 | 0.666M |
November 30, 2021 | 0.674M |
August 31, 2021 | 0.683M |
May 31, 2021 | 0.681M |
February 28, 2021 | 0.665M |
November 30, 2020 | 0.674M |
August 31, 2020 | 0.681M |
May 31, 2020 | 0.681M |
February 29, 2020 | 0.674M |
November 30, 2019 | 0.674M |
Date | Value |
---|---|
August 31, 2019 | 0.681M |
May 31, 2019 | 0.682M |
February 28, 2019 | 0.666M |
November 30, 2018 | 0.674M |
August 31, 2018 | 0.617M |
May 31, 2018 | 0.617M |
February 28, 2018 | 0.604M |
November 30, 2017 | 0.611M |
August 31, 2017 | 0.618M |
May 31, 2017 | 0.617M |
February 28, 2017 | 0.611M |
November 30, 2016 | 0.61M |
August 31, 2016 | 0.353M |
May 31, 2016 | 0.163M |
February 29, 2016 | 0.125M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.665M
Minimum
Feb 2021
0.683M
Maximum
Aug 2021
0.6761M
Average
0.674M
Median
Nov 2019
Revenue (Quarterly) Benchmarks
Inogen Inc | 75.90M |
Petros Pharmaceuticals Inc | -0.3643M |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 3.727M |
Palatin Technologies Inc | 2.034M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 13.34M |
Total Expenses (Quarterly) | 3.877M |
EPS Diluted (Quarterly) | 0.33 |
Enterprise Value | -17.55M |
Earnings Yield | 6.38% |
Normalized Earnings Yield | -23.23 |